Ovid Therapeutics Receives Orphan Drug Designation from the European Commission for OV101 Biotech Investing
Cannabis Big News Roundup: TILT Added to Horizons US Marijuana Index; Inner Spirit Holdings Announces Opening of First Corporate Stores; FSD Pharma Receives Full “Sales for Medical Purposes” License Cannabis Investing News
Life Sciences Big News Roundup: Green Growth Brands Announces Expansion with Abercrombie & Fitch Distribution; Krystal Biotech Announces Phase 2 Clinical Trial Results; Dova Pharmaceuticals Announces European Union Marketing Authorization Life Science Investing News
Green Growth Brands Announces Expansion with Abercrombie & Fitch to Sell Seventh Sense CBD Products in over 160 Stores Cannabis Investing News
Ziopharm Oncology Completes Enrollment of Controlled IL-12 plus Opdivo Phase 1 Combination Trial Pharmaceutical Investing
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
